Course Description2019-06-21T16:57:17+00:00

Course Description

The United Mitochondrial Disease Foundation and PeerPoint Medical Education Institute have joined efforts to sponsor and organize a CME-accredited symposium. Mitochondrial diseases are more common than previously recognized and mitochondrial pathophysiology is now a recognized part of many disease processes, including heart disease, cancer, AIDS and diabetes. There have been significant advances in the molecular genetics, proteomics, epidemiology and clinical aspects of mitochondrial pathophysiology. This conference is directed toward the scientist and clinician interested in all aspects of mitochondrial science. The content of this educational program was determined by rigorous assessment of educational needs and includes surveys, program feedback, expert faculty assessment, literature review, medical practice, chart review and new medical knowledge. The format will include didactic lectures from invited experts intermixed with peer-reviewed platform presentations. There will be ample time for professional discussion both in and out of the meeting room, and peer-reviewed poster presentations will be given throughout the meeting. This will be a four-day scientific meeting aimed at those with scientific and clinical interests.


TARGET AUDIENCE

Neurologists, Geneticists, Researchers/Scientists, Pediatrics, Internal Medicine, Nephrologists, Cardiologists, Endocrinologists, Genetic Counselors, Advanced Practice Nurses, Physicians Assistants, RNs, Occupational Therapy, Physical Therapy and Speech-Language Pathology, Nutritional Therapy, and Residents/Fellows/Students.


LEARNING OBJECTIVES

  • Learn about new clinical trials investigating treatments for mitochondrial diseases in children and adults
  • Become familiar with new insights the technology of mitochondrial transfer as it relates to possible treatment for mitochondrial disease.
  • Learn how the use of true Whole Genome Sequencing can be applied to diagnose mitochondrial diseases
  • Summarize the development of consortium-based discovery and care networks are changing the face of clinical practice as it relates to mitochondrial medicine.
  • Discover the role of the US Food and Drug Administration in the approval process for treatments of rare diseases including mitochondrial disease.
  • Understand the application of iPS cells for Leigh syndrome diagnostics and possible therapy
  • Describe the interactions between mitochondrial and the microbiota.
  • Learn about innate immunity and the role of the mitochondria in innate immunity and immunity in those with known mitochondrial diseases.
  • Learn of the advances in the understanding of organelle cross-talk and mitochondrial dynamics
  • Discover the role of mitochondrial epigenetics and the process of DNA methylation of the mtDNA

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and United Mitochondrial Disease Foundation. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 18.50 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

2019 Scientific Meeting – Confirmed Faculty

  • Dario C. Altieri, MD, Wistar Institute Cancer Center, Philadelphia, PA
  • Ana Andreazza, PhD, University of Toronto, Toronto, Canada
  • Brendan Battersby, PhD, University of Helsinki, Institute of Biotechnology, Finland
  • Patrick Chinnery, MBBS, PhD, FRCP, FMedSci, University of Cambridge, Cambridge, UK
  • William Copeland, PhD, NIEHS, Research Triangle Park, NC
  • David Dimmock, MD, Rady Children’s Institute for Genomic Medicine, San Diego, CA
  • Marni Falk, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Amy Goldstein, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Michio Hirano, MD, Columbia University, New York, NY
  • Adam Hughes, PhD, University of Utah School of Medicine, Salt Lake City, UT
  • Shilpa Iyer, PhD, University of Arkansas, Fayetteville, AR
  • Amel Karaa, MD, Massachusetts General Hospital, Boston, MA
  • Carla Koehler, PhD, University of California Los Angeles, Los Angeles, CA
  • Mary Kay Koenig, MD, University of Texas McGovern Medical School, Houston, TX
  • Danuta  Krotoski, PhD, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD
  • Austin Larson, MD, Children’s Hospital Colorado, Denver, CO
  • David Lynch, MD, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Peter McGuire, MS, MBBCh, Metabolism, Infection and Immunity Section, National Human Genome Research Institute, NIH, Bethesda, MD
  • Vamsi K. Mootha, MD, Harvard Medical School, Boston, MA
  • Sumit Parikh, MD, The Cleveland Clinic, Cleveland, OH
  • Anne  Pariser, MD, NIH/National Center for Advancing Translational Sciences (NCATS), Bethesda, MD
  • William Prinz, PhD, NIH/National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD
  • Shamima Rahman, FRCP PhD, UCL Great Ormond Street Institute of Child Health, London, UK
  • David Shackelford, PhD, University of California Los Angeles (UCLA) David Geffen School of Medicine, CA
  • David J. Livingston, PhD, Brown University, Providence, RI
  • Keshav K. Singh, PhD, University of Alabama at Birmingham, AL
  • Michael Teitell, MD, PhD, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, CA
  • David Thorburn, PhD, Murdoch Children’s Research Institute, Melbourne, Australia
  • Douglas C.  Wallace, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA
  • A. Phillip West, PhD, Texas A&M University College of Medicine, College Station, TX
  • Takehiro Yasukawa, PhD, Department of Clinical Chemistry and Laboratory Medicine Graduate School of Medical Sciences, Kyushu University
  • Philip Yeske, PhD, UMDF, Science & Alliance Officer, Pittsburgh, PA

SPEAKERS & DISCLOSURES

Click Here for Final Accreditation and Designation Statements and Disclosure Report

2019 Scientific Symposium Planning Committee

  • Amel Karaa, MD, 2019 Course Co-Chair, Massachusetts General Hospital, Boston, MA
  • Carla Koehler, PhD, 2019 Course Co-Chair, University of California Los Angeles, Los Angeles, CA
  • Bruce H. Cohen, MD, 2019 CME Chair, Akron Children’s Hospital, Akron, OH
  • William Copeland, PhD, NIEHS, Research Triangle Park, NC
  • Amy Goldstein, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Larry Grossman, PhD, Wayne State University School of Medicine, Detroit, MI
  • Adam Hartman, MD, NINDS/NIH, Rockville, MD
  • Gene Kelly, UMDF Industry Advisor Council, Chair, Stealth BioTherapeutics, Boston, MA
  • Giovanni Manfredi, MD, PhD, Weill Cornell Medicine, New York, NY
  • Robert K. Naviaux, MD, PhD, University of California San Diego, San Diego, CA
  • Sumit Parikh, MD, The Cleveland Clinic, Cleveland, OH
  • Russell Saneto, DO, PhD, Course Chair, Seattle Children’s Research Institute, Seattle, WA
  • Peter Stacpoole, PhD, MD, University of Florida, Gainesville, FL
  • Keshav Singh, PhD, University of Alabama at Birmingham, AL
  • Philip E. Yeske, PhD, UMDF Science & Alliance Officer, Pittsburgh, PA
  • Kara Strittmatter, CMM, MA, UMDF Meeting Event Director, Columbus, OH

 For more information on continuing education (CME), please email symposium@umdf.org or call 888-317-UMDF.

Symposium Links

Sponsor Today!

Contact Beth Whitehouse at bethw@umdf.org for more information on sponsorship opportunities

Every time I attend it gets better and better . . . speakers, networking, etc. and especially the last 2-3 years, clinical trial/studies part of program. Great to see more in attendance!
Gail Wehling, Illinois
Talking with doctors and researchers! So helpful. Teen sessions… My kids loved feeling a part of a group of teens that were “like them.”
Laura Ursiny, Michigan
For our family, this symposium was transformational. We have been given hope. For our daughter, she now has friends who get her!
Patti Wood, California